Pliant Therapeutics Appoints Chief Medical Officer
Pliant Therapeutics Inc. has appointed David Raben, M.D., as its Chief Medical Officer.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
3 results loaded, newest first. End of these results.
Pliant Therapeutics Appoints David Raben as Chief Medical Officer
Pliant Therapeutics appointed David Raben, M.D., as Chief Medical Officer and granted him options for 575,000 shares vesting over four years. This move is intended to strengthen execution of Pliant’s oncology pipeline.
Pliant Therapeutics appoints David Raben as chief medical officer
Pliant Therapeutics said it appointed David Raben, M.D., as chief medical officer.